ClinicalTrials.Veeva

Menu

A Multicenter Randomized Controlled Study of 3D Laparoscopy Versus Endoscopy in the Treatment of Choledocholithiasis

Fudan University logo

Fudan University

Status

Not yet enrolling

Conditions

ERCP
Choledocholithiasis

Treatments

Procedure: ERCP
Procedure: 3D LCBDE

Study type

Interventional

Funder types

Other

Identifiers

NCT04658212
ZSBS-LSES-1

Details and patient eligibility

About

The incidence of choledocholithiasis is gradually rising with the increase of gallstone incidence. The popular minimally invasive treatment options include endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic common bile duct exploration (LCBDE). Currently, three-dimensional (3D) video system for laparoscopy is developed to ofer surgeon a superior depth perception and a much better user experience, thus potential increasing operation accuracy and stability. It have suggested that compared with 2D laparoscopy, 3D laparoscopy can effectively reduce operation time and numbers of errors. However, rare experimental studies are performed to evaluate the safety and effectiveness of 3D laparoscopy in choledocholithiasis patients. The aim of this study is to compare the perioperative outcomes between 3D laparoscopy and ERCP in choledocholithiasis patients through a multicenter randomized controlled design.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The diagnosis of choledocholithiasis based on preoperative image studies including abdominal ultrasonography, computed tomography (CT), and/or magnetic resonance cholangiopancreatography (MRCP) with relevant supporting laboratory examinations
  2. Age <80y and >18y
  3. Non-emergency surgery

Exclusion criteria

  1. Diagnosis of Mirizzi's syndrome,
  2. Acute suppurative cholangitis
  3. Detection of bilioenteric anastomosis
  4. Pathological diagnosis of cholangiocarcinoma
  5. Extended surgery due to multiple biliary strictures,
  6. Intrahepatic stones

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

300 participants in 2 patient groups

3D LCBDE group
Experimental group
Treatment:
Procedure: 3D LCBDE
ERCP group
Active Comparator group
Treatment:
Procedure: ERCP

Trial contacts and locations

0

Loading...

Central trial contact

Yueqi Wang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems